Source |
Code |
Name |
Case count |
Share of cases (%) |
PURCH |
PURCH_ATC(A10BA02) |
Metformin |
43387 |
|
REIMB |
REIMB_KELA(103)_ICD10(E11) |
Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus |
29905 |
|
REIMB |
REIMB_KELA(215)_ICD10(E11) |
Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus |
27386 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E119) |
Non-insulin-dependent diabetes mellitus - Without complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
20106 |
|
OUTPAT |
OUTPAT_ICD10(E119) |
Non-insulin-dependent diabetes mellitus - Without complications |
17820 |
|
INPAT |
INPAT_ICD10(E119) |
Non-insulin-dependent diabetes mellitus - Without complications |
16960 |
|
PURCH |
PURCH_ATC(A10BH01) |
Sitagliptin |
12548 |
|
PURCH |
PURCH_ATC(A10BB12) |
Glimepiride |
9188 |
|
PURCH |
PURCH_ATC(A10BK03) |
Empagliflozin |
6122 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E118) |
Non-insulin-dependent diabetes mellitus - With unspecified complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
5263 |
|
REIMB |
REIMB_KELA(103)_ICD10(E119) |
Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - Without complications |
4893 |
|
PURCH |
PURCH_ATC(A10BD07) |
Metformin and sitagliptin |
4865 |
|
INPAT |
INPAT_ICD10(E118) |
Non-insulin-dependent diabetes mellitus - With unspecified complications |
4778 |
|
REIMB |
REIMB_KELA(215)_ICD10(E119) |
Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - Without complications |
4764 |
|
PURCH |
PURCH_ATC(A10BH05) |
Linagliptin |
4507 |
|
PURCH |
PURCH_ATC(A10BB01) |
Glibenclamide |
4308 |
|
OUTPAT |
OUTPAT_ICD10(E118) |
Non-insulin-dependent diabetes mellitus - With unspecified complications |
3956 |
|
PURCH |
PURCH_ATC(A10BK01) |
Dapagliflozin |
3217 |
|
PURCH |
PURCH_ATC(A10BX01) |
Guar gum |
3135 |
|
REIMB |
REIMB_KELA(285)_ICD10(E11) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus |
2706 |
|
REIMB |
REIMB_KELA(346)_ICD10(E11) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus |
2509 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E117) |
Non-insulin-dependent diabetes mellitus - With multiple complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
2478 |
|
PURCH |
PURCH_ATC(A10BG03) |
Pioglitazone |
2471 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E112) |
Non-insulin-dependent diabetes mellitus - With renal complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
2393 |
|
INPAT |
INPAT_ICD10(E1100) |
Non-insulin dependent diabetes diabetic hypoglycaemic coma |
2371 |
|
OUTPAT |
OUTPAT_ICD10(E117) |
Non-insulin-dependent diabetes mellitus - With multiple complications |
2257 |
|
PURCH |
PURCH_ATC(A10BJ02) |
Liraglutide |
2188 |
|
INPAT |
INPAT_ICD10(E117) |
Non-insulin-dependent diabetes mellitus - With multiple complications |
2099 |
|
PURCH |
PURCH_ATC(A10BH02) |
Vildagliptin |
1958 |
|
OUTPAT |
OUTPAT_ICD10(E113) |
Non-insulin-dependent diabetes mellitus - With ophthalmic complications |
1896 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E114) |
Non-insulin-dependent diabetes mellitus - With neurological complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
1832 |
|
REIMB |
REIMB_KELA(160)_ICD10(E11) |
exenatide, Non-insulin-dependent diabetes mellitus |
1721 |
|
DEATH |
DEATH_ICD10(E119) |
Non-insulin-dependent diabetes mellitus - Without complications |
1713 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E113) |
Non-insulin-dependent diabetes mellitus - With ophthalmic complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
1614 |
|
INPAT |
INPAT_ICD9(2500A) |
Diabetes mellitus without mention of complication |
1579 |
|
PURCH |
PURCH_ATC(A10BD03) |
Metformin and rosiglitazone |
1411 |
|
PURCH |
PURCH_ATC(A10BG02) |
Rosiglitazone |
1323 |
|
OUTPAT |
OUTPAT_ICD10(E112) |
Non-insulin-dependent diabetes mellitus - With renal complications |
1225 |
|
PURCH |
PURCH_ATC(A10BX07) |
Liraglutide |
1202 |
|
OUTPAT |
OUTPAT_ICD10(E1100) |
Non-insulin dependent diabetes diabetic hypoglycaemic coma |
1198 |
|
PURCH |
PURCH_ATC(A10BB07) |
Glipizide |
1186 |
|
PURCH |
PURCH_ATC(A10BX02) |
Repaglinide |
992 |
|
PURCH |
PURCH_ATC(A10BX04) |
Exenatide |
964 |
|
OUTPAT |
OUTPAT_ICD10(E115) |
Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications |
886 |
|
INPAT |
INPAT_ICD10(E115) |
Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications |
854 |
|
INPAT |
INPAT_ICD10(E112) |
Non-insulin-dependent diabetes mellitus - With renal complications |
824 |
|
REIMB |
REIMB_KELA(177)_ICD10(E11) |
Insulin glargine 300 U / ml, Non-insulin-dependent diabetes mellitus |
822 |
|
OUTPAT |
OUTPAT_ICD10(E114) |
Non-insulin-dependent diabetes mellitus - With neurological complications |
807 |
|
PURCH |
PURCH_ATC(A10BX09) |
Dapagliflozin |
804 |
|
REIMB |
REIMB_KELA(162)_ICD10(E11) |
liraglutide, Non-insulin-dependent diabetes mellitus |
794 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E116) |
Non-insulin-dependent diabetes mellitus - With other specified complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
785 |
|
PURCH |
PURCH_ATC(A10BJ01) |
Exenatide |
759 |
|
PURCH |
PURCH_ATC(A10BJ06) |
Name not found |
757 |
|
PURCH |
PURCH_ATC(A10BD08) |
Metformin and vildagliptin |
719 |
|
REIMB |
REIMB_KELA(285)_ICD10(E119) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - Without complications |
590 |
|
REIMB |
REIMB_KELA(103)_ICD10(E118) |
Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With unspecified complications |
583 |
|
OUTPAT |
OUTPAT_ICD10(E116) |
Non-insulin-dependent diabetes mellitus - With other specified complications |
579 |
|
REIMB |
REIMB_KELA(215)_ICD10(E118) |
Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With unspecified complications |
575 |
|
INPAT |
INPAT_ICD10(E116) |
Non-insulin-dependent diabetes mellitus - With other specified complications |
529 |
|
PURCH |
PURCH_ATC(A10BJ05) |
Dulaglutide |
518 |
|
INPAT |
INPAT_ICD10(E113) |
Non-insulin-dependent diabetes mellitus - With ophthalmic complications |
513 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E115) |
Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
509 |
|
PURCH |
PURCH_ATC(A10BD20) |
Metformin and empagliflozin |
498 |
|
REIMB |
REIMB_KELA(346)_ICD10(E119) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - Without complications |
471 |
|
DEATH |
DEATH_ICD10(E117) |
Non-insulin-dependent diabetes mellitus - With multiple complications |
464 |
|
INPAT |
INPAT_ICD10(E114) |
Non-insulin-dependent diabetes mellitus - With neurological complications |
421 |
|
PURCH |
PURCH_ATC(A10BD15) |
Metformin and dapagliflozin |
405 |
|
PURCH |
PURCH_ATC(A10BD05) |
Metformin and pioglitazone |
404 |
|
DEATH |
DEATH_ICD10(E118) |
Non-insulin-dependent diabetes mellitus - With unspecified complications |
378 |
|
REIMB |
REIMB_KELA(358)_ICD10(E11) |
liraglutide, Non-insulin-dependent diabetes mellitus |
337 |
|
REIMB |
REIMB_KELA(310)_ICD10(E11) |
Orlistat, sibutramine and other major and expensive medicines used to treat obesity, Non-insulin-dependent diabetes mellitus |
314 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E1100) |
Non-insulin dependent diabetes diabetic hypoglycaemic coma. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
261 |
|
PURCH |
PURCH_ATC(A10BD11) |
Metformin and linagliptin |
235 |
|
REIMB |
REIMB_KELA(160)_ICD10(E119) |
exenatide, Non-insulin-dependent diabetes mellitus - Without complications |
232 |
|
DEATH |
DEATH_ICD10(E112) |
Non-insulin-dependent diabetes mellitus - With renal complications |
192 |
|
REIMB |
REIMB_KELA(162)_ICD10(E119) |
liraglutide, Non-insulin-dependent diabetes mellitus - Without complications |
171 |
|
INPAT |
INPAT_ICD10(E111) |
Non-insulin-dependent diabetes mellitus - With ketoacidosis |
160 |
|
PURCH |
PURCH_ATC(A10BH03) |
Saxagliptin |
160 |
|
INPAT |
INPAT_ICD9(2507A) |
Diabetes mellitus, Diabetes with peripheral circulatory disorders |
140 |
|
OUTPAT |
OUTPAT_ICD10(E111) |
Non-insulin-dependent diabetes mellitus - With ketoacidosis |
137 |
|
OUTPAT |
OUTPAT_ICD10(E1101) |
Non-insulin dependent diabetes diabetic coma with hyperglycaemia |
117 |
|
INPAT |
INPAT_ICD10(E1109) |
Non-insulin-dependent diabetes mellitus - With coma |
111 |
|
INPAT |
INPAT_ICD9(2505A) |
Diabetes mellitus, Diabetes with ophthalmic manifestations |
106 |
|
PURCH |
PURCH_ATC(A10BX12) |
Empagliflozin |
104 |
|
REIMB |
REIMB_KELA(358)_ICD10(E119) |
liraglutide, Non-insulin-dependent diabetes mellitus - Without complications |
84 |
|
REIMB |
REIMB_KELA(285)_ICD10(E117) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With multiple complications |
82 |
|
OUTPAT |
OUTPAT_ICD10(E1109) |
Non-insulin-dependent diabetes mellitus - With coma |
78 |
|
REIMB |
REIMB_KELA(103)_ICD10(E112) |
Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With renal complications |
73 |
|
REIMB |
REIMB_KELA(215)_ICD10(E112) |
Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With renal complications |
71 |
|
REIMB |
REIMB_KELA(346)_ICD10(E118) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With unspecified complications |
70 |
|
DEATH |
DEATH_ICD9(2500A) |
Diabetes mellitus without mention of complication |
69 |
|
REIMB |
REIMB_KELA(346)_ICD10(E117) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With multiple complications |
65 |
|
REIMB |
REIMB_KELA(285)_ICD10(E118) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With unspecified complications |
64 |
|
REIMB |
REIMB_KELA(103)_ICD10(E117) |
Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With multiple complications |
60 |
|
DEATH |
DEATH_ICD10(E115) |
Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications |
57 |
|
INPAT |
INPAT_ICD10(E1101) |
Non-insulin dependent diabetes diabetic coma with hyperglycaemia |
57 |
|
REIMB |
REIMB_KELA(103)_ICD10(E114) |
Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With neurological complications |
56 |
|
REIMB |
REIMB_KELA(215)_ICD10(E114) |
Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With neurological complications |
55 |
|
REIMB |
REIMB_KELA(103)_ICD10(E116) |
Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With other specified complications |
53 |
|
REIMB |
REIMB_KELA(346)_ICD10(E112) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With renal complications |
51 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E111) |
Non-insulin-dependent diabetes mellitus - With ketoacidosis. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
50 |
|
REIMB |
REIMB_KELA(215)_ICD10(E116) |
Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With other specified complications |
50 |
|
REIMB |
REIMB_KELA(285)_ICD10(E112) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With renal complications |
50 |
|
PURCH |
PURCH_ATC(A10BD19) |
Linagliptin and empagliflozin |
48 |
|
REIMB |
REIMB_KELA(215)_ICD10(E117) |
Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With multiple complications |
47 |
|
REIMB |
REIMB_KELA(177)_ICD10(E119) |
Insulin glargine 300 U / ml, Non-insulin-dependent diabetes mellitus - Without complications |
46 |
|
DEATH |
DEATH_ICD10(E116) |
Non-insulin-dependent diabetes mellitus - With other specified complications |
44 |
|
PURCH |
PURCH_ATC(A10BH04) |
Alogliptin |
44 |
|
PURCH |
PURCH_ATC(A10BX03) |
Nateglinide |
41 |
|
REIMB |
REIMB_KELA(103)_ICD9(E11) |
Diabetes, insulin-treated, Name not found |
37 |
|
INPAT |
INPAT_ICD9(2503A) |
Diabetes mellitus, Diabetes with other coma |
35 |
|
PURCH |
PURCH_ATC(A10BD10) |
Metformin and saxagliptin |
35 |
|
INPAT |
INPAT_ICD9(2506A) |
Diabetes mellitus, Diabetes with neurological manifestations |
34 |
|
REIMB |
REIMB_KELA(103)_ICD10(E113) |
Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With ophthalmic complications |
33 |
|
INPAT |
INPAT_ICD9(2508A) |
Diabetes mellitus, Diabetes with other specified manifestations |
32 |
|
REIMB |
REIMB_KELA(346)_ICD10(E113) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With ophthalmic complications |
32 |
|
DEATH |
DEATH_ICD10(E110) |
Name not found |
31 |
|
REIMB |
REIMB_KELA(103)_ICD10(E110) |
Diabetes, insulin-treated, Name not found |
31 |
|
REIMB |
REIMB_KELA(215)_ICD10(E113) |
Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With ophthalmic complications |
31 |
|
REIMB |
REIMB_KELA(285)_ICD10(E113) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With ophthalmic complications |
31 |
|
PURCH |
PURCH_ATC(A10BK02) |
Kanagliflozin |
30 |
|
DEATH |
DEATH_ICD10(E114) |
Non-insulin-dependent diabetes mellitus - With neurological complications |
28 |
|
REIMB |
REIMB_KELA(215)_ICD10(E110) |
Diabetes, non-insulin-treated, Name not found |
27 |
|
REIMB |
REIMB_KELA(160)_ICD10(E117) |
exenatide, Non-insulin-dependent diabetes mellitus - With multiple complications |
26 |
|
REIMB |
REIMB_KELA(285)_ICD10(E114) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With neurological complications |
26 |
|
DEATH |
DEATH_ICD9(2507A) |
Diabetes mellitus, Diabetes with peripheral circulatory disorders |
25 |
|
REIMB |
REIMB_KELA(346)_ICD10(E114) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With neurological complications |
24 |
|
INPAT |
INPAT_ICD9(2504A) |
Diabetes mellitus, Diabetes with renal manifestations |
23 |
|
REIMB |
REIMB_KELA(162)_ICD10(E117) |
liraglutide, Non-insulin-dependent diabetes mellitus - With multiple complications |
23 |
|
REIMB |
REIMB_KELA(162)_ICD10(E112) |
liraglutide, Non-insulin-dependent diabetes mellitus - With renal complications |
22 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E1109) |
Non-insulin-dependent diabetes mellitus - With coma. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
20 |
|
REIMB |
REIMB_KELA(160)_ICD10(E112) |
exenatide, Non-insulin-dependent diabetes mellitus - With renal complications |
20 |
|
REIMB |
REIMB_KELA(162)_ICD10(E118) |
liraglutide, Non-insulin-dependent diabetes mellitus - With unspecified complications |
20 |
|
REIMB |
REIMB_KELA(103)_ICD10(E111) |
Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With ketoacidosis |
19 |
|
REIMB |
REIMB_KELA(160)_ICD10(E118) |
exenatide, Non-insulin-dependent diabetes mellitus - With unspecified complications |
19 |
|
REIMB |
REIMB_KELA(215)_ICD10(E111) |
Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With ketoacidosis |
16 |
|
PURCH |
PURCH_ATC(A10BD09) |
Pioglitazone and alogliptin |
15 |
|
DEATH |
DEATH_ICD10(E111) |
Non-insulin-dependent diabetes mellitus - With ketoacidosis |
14 |
|
OUTPAT |
OUTPAT_ICD10(E110) |
Name not found |
14 |
|
PURCH |
PURCH_ATC(A10BD13) |
Metformin and alogliptin |
14 |
|
REIMB |
REIMB_KELA(285)_ICD10(E116) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With other specified complications |
14 |
|
REIMB |
REIMB_KELA(358)_ICD10(E112) |
liraglutide, Non-insulin-dependent diabetes mellitus - With renal complications |
14 |
|
DEATH |
DEATH_ICD10(E113) |
Non-insulin-dependent diabetes mellitus - With ophthalmic complications |
13 |
|
PURCH |
PURCH_ATC(A10BJ03) |
Lixisenatide |
12 |
|
PURCH |
PURCH_ATC(A10BK04) |
Name not found |
12 |
|
REIMB |
REIMB_KELA(160)_ICD10(E114) |
exenatide, Non-insulin-dependent diabetes mellitus - With neurological complications |
12 |
|
PURCH |
PURCH_ATC(A10BD21) |
Saxagliptin and dapagliflozin |
11 |
|
REIMB |
REIMB_KELA(103)_ICD10(E115) |
Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications |
11 |
|
REIMB |
REIMB_KELA(346)_ICD10(E116) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With other specified complications |
10 |
|
REIMB |
REIMB_KELA(160)_ICD10(E113) |
exenatide, Non-insulin-dependent diabetes mellitus - With ophthalmic complications |
9 |
|
REIMB |
REIMB_KELA(162)_ICD10(E114) |
liraglutide, Non-insulin-dependent diabetes mellitus - With neurological complications |
9 |
|
REIMB |
REIMB_KELA(215)_ICD10(E115) |
Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications |
9 |
|
REIMB |
REIMB_KELA(310)_ICD10(E119) |
Orlistat, sibutramine and other major and expensive medicines used to treat obesity, Non-insulin-dependent diabetes mellitus - Without complications |
8 |
|
PURCH |
PURCH_ATC(A10BB02) |
Chlorpropamide |
7 |
|
PURCH |
PURCH_ATC(A10BX10) |
Lixisenatid |
7 |
|
REIMB |
REIMB_KELA(358)_ICD10(E117) |
liraglutide, Non-insulin-dependent diabetes mellitus - With multiple complications |
7 |
|
REIMB |
REIMB_KELA(160)_ICD10(E116) |
exenatide, Non-insulin-dependent diabetes mellitus - With other specified complications |
6 |
|
REIMB |
REIMB_KELA(162)_ICD10(E113) |
liraglutide, Non-insulin-dependent diabetes mellitus - With ophthalmic complications |
6 |
|
REIMB |
REIMB_KELA(177)_ICD10(E118) |
Insulin glargine 300 U / ml, Non-insulin-dependent diabetes mellitus - With unspecified complications |
6 |
|
DEATH |
DEATH_ICD9(2505A) |
Diabetes mellitus, Diabetes with ophthalmic manifestations |
5 |
|
DEATH |
DEATH_ICD9(2506A) |
Diabetes mellitus, Diabetes with neurological manifestations |
5 |
|
DEATH |
DEATH_ICD9(2508A) |
Diabetes mellitus, Diabetes with other specified manifestations |
5 |
|
REIMB |
REIMB_KELA(285)_ICD10(E115) |
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications |
5 |
|